Expert Opinion on Medical Diagnostics · 2010 · 43 citations · 76 references
MedicineOncologyPathologyDiagnostic ImagingGenitourinary OncologyMetastasisProstate BiopsyProstate CancerProstate PathologyTumor CharacterizationTumor DetectionTumor MorphologyBiopsy Of Prostate LesionsPrognostic Tumor MarkersProstate Biopsy DiagnosisProstate Cancer DiagnosisProstate Cancer HistopathologyProstate Lesion CharacterizationProstate Needle Biopsy DiagnosisProstate Tumor Markers
IMPORTANCE OF THE FIELD: Prostate cancer is a common and multifocal disease but the diagnostic methods available are unsatisfactory. Most tumors present are of low malignant potential, whereas others are highly aggressive. At present, imaging cannot be used to guide tissue biopsies safely towards the most aggressive tumor present. To handle this problem multiple needle biopsies are taken. The biopsies often contain only normal prostate tissue, and even if the tumor is sampled it is not known whether a more aggressive cancer is present elsewhere in the organ. If changes in the normal tissue indicate the presence and nature of tumors, this information could be used to improve diagnostics and prognostics of prostate cancer. AREAS COVERED IN THIS REVIEW: Current evidence that the tumor-adjacent morphologically normal prostate tissue is not completely normal is reviewed, and that this tissue, named tumor indicating normal tissue (TINT) by the authors, can be used to diagnose prostate cancer. WHAT THE READER WILL GAIN: The reader will understand that tumors need to affect their surroundings in order to grow and metastasize and that the normal prostate tissue is therefore tinted by the presence and nature of cancer and that this knowledge can be used to develop new diagnostic and prognostic markers. TAKE HOME MESSAGE: TINT changes could probably, when more rigorously defined and validated, be used to diagnose and prognosticate prostate cancer.
76
Natural History of Early, Localized Prostate Cancer
Jan-Erik Johansson · JAMA · 2004 · 711 citations
Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin
Sandra S. McAllister, Ann Gifford, Ashley Greiner et al. · Cell · 2008 · 428 citations · Full text
Medicine, Endocrinology, Oncology +10
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
Gustavo Ayala, Jennifer A. Tuxhorn, Thomas M. Wheeler et al. · PubMed · 2003 · 358 citations